对冒烟型多发性骨髓瘤进行人群筛查显示其患病率很高。 - Suppr

Suppr

超能文献

Population screening for smoldering multiple myeloma reveals high prevalence.

出版信息

Nat Med. 2023 Feb;29(2):313-314. doi: 10.1038/s41591-022-02187-2.

DOI:10.1038/s41591-022-02187-2

PMID:36755165

Abstract

摘要

相似文献

Population screening for smoldering multiple myeloma reveals high prevalence.

Nat Med. 2023 Feb;29(2):313-314. doi: 10.1038/s41591-022-02187-2.

Should high risk smoldering myeloma be treated outside a clinical trial: NO.

Leuk Lymphoma. 2021 Nov;62(11):2565-2567. doi: 10.1080/10428194.2021.1951723. Epub 2021 Jul 14.

The impact of CD56 expression in smoldering myeloma patients on early progression.

Hematol Oncol. 2023 Aug;41(3):587-589. doi: 10.1002/hon.3104. Epub 2022 Dec 1.

Is aggressive treatment of smoldering myeloma the path to curing myeloma?

Blood Adv. 2023 Aug 8;7(15):3932-3935. doi: 10.1182/bloodadvances.2023009658.

Smoldering Myeloma Treatment: Who, What, and When.

Cancer J. 2021;27(3):185-189. doi: 10.1097/PPO.0000000000000528.

Risk Stratification of Precursors to Multiple Myeloma in 2020.

R I Med J (2013). 2020 Apr 1;103(3):46-47.

The consultant's guide to smoldering multiple myeloma.

Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):551-559. doi: 10.1182/hematology.2022000355.

Diagnosis and Management of Monoclonal Gammopathy and Smoldering Multiple Myeloma.

J Natl Compr Canc Netw. 2020 Dec 1;18(12):1720-1729. doi: 10.6004/jnccn.2020.7660.

Serum markers alone can define high-risk smouldering multiple myeloma: new insights from the Czech Myeloma Group model.

Br J Haematol. 2020 Jul;190(2):137-138. doi: 10.1111/bjh.16598. Epub 2020 Mar 27.

Progress in the Management of Smoldering Multiple Myeloma.

Curr Hematol Malig Rep. 2021 Apr;16(2):172-182. doi: 10.1007/s11899-021-00623-7. Epub 2021 May 13.

引用本文的文献

Update on the outcome of M-protein screening program of multiple myeloma in China: A 7-year cohort study.

Cancer Med. 2024 Jan;13(1):e6859. doi: 10.1002/cam4.6859. Epub 2023 Dec 22.

本文引用的文献

How I approach smoldering multiple myeloma.

Blood. 2022 Aug 25;140(8):828-838. doi: 10.1182/blood.2021011670.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Population screening for smoldering multiple myeloma reveals high prevalence.

Nat Med. 2023 Feb;29(2):313-314. doi: 10.1038/s41591-022-02187-2.

Should high risk smoldering myeloma be treated outside a clinical trial: NO.

Leuk Lymphoma. 2021 Nov;62(11):2565-2567. doi: 10.1080/10428194.2021.1951723. Epub 2021 Jul 14.

The impact of CD56 expression in smoldering myeloma patients on early progression.

Hematol Oncol. 2023 Aug;41(3):587-589. doi: 10.1002/hon.3104. Epub 2022 Dec 1.

Is aggressive treatment of smoldering myeloma the path to curing myeloma?

Blood Adv. 2023 Aug 8;7(15):3932-3935. doi: 10.1182/bloodadvances.2023009658.

Smoldering Myeloma Treatment: Who, What, and When.

Cancer J. 2021;27(3):185-189. doi: 10.1097/PPO.0000000000000528.

Risk Stratification of Precursors to Multiple Myeloma in 2020.

R I Med J (2013). 2020 Apr 1;103(3):46-47.

The consultant's guide to smoldering multiple myeloma.

Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):551-559. doi: 10.1182/hematology.2022000355.

Diagnosis and Management of Monoclonal Gammopathy and Smoldering Multiple Myeloma.

J Natl Compr Canc Netw. 2020 Dec 1;18(12):1720-1729. doi: 10.6004/jnccn.2020.7660.

Serum markers alone can define high-risk smouldering multiple myeloma: new insights from the Czech Myeloma Group model.

Br J Haematol. 2020 Jul;190(2):137-138. doi: 10.1111/bjh.16598. Epub 2020 Mar 27.

Progress in the Management of Smoldering Multiple Myeloma.

Curr Hematol Malig Rep. 2021 Apr;16(2):172-182. doi: 10.1007/s11899-021-00623-7. Epub 2021 May 13.

引用本文的文献

Update on the outcome of M-protein screening program of multiple myeloma in China: A 7-year cohort study.

Cancer Med. 2024 Jan;13(1):e6859. doi: 10.1002/cam4.6859. Epub 2023 Dec 22.

本文引用的文献

How I approach smoldering multiple myeloma.

Blood. 2022 Aug 25;140(8):828-838. doi: 10.1182/blood.2021011670.